BR55: A Lipopeptide-Based VEGFR2-Targeted Ultrasound Contrast Agent for Molecular Imaging of Angiogenesis
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: BR55, an ultrasound contrast agent functionalized with a heterodimer peptide targeting the vascular endothelial growth factor receptor 2 (VEGFR2), was evaluated in vitro and in vivo, demonstrating its potential for specific tumor detection. MATERIALS AND METHODS: The targeted contrast agent was prepared by incorporation of a biospecific lipopeptide into the microbubble membrane. Experiments were performed in vitro to demonstrate the binding capacities of BR55 microbubbles on immobilized receptor proteins and on various endothelial or transfected cells expressing VEGFR2. The performance of BR55 microbubbles was compared with that of streptavidin-conjugated microbubbles targeted to the same receptor by coupling them to a biotinylated antibody. The specificity of BR55 binding to human and mouse endothelial cells was determined in competition experiments with the free lipopeptide, vascular endothelial growth factor (VEGF), or a VEGFR2-specific antibody. Molecular ultrasound imaging of VEGFR2 was performed in an orthotopic breast tumor model in rats using a nondestructive, contrast-specific imaging mode. RESULTS: BR55 was shown to bind specifically to the immobilized recombinant VEGFR2 under flow (dynamic conditions). BR55 accumulation on the target over time was similar to that of microbubbles bearing a specific antibody. BR55 avidly bound to cells expressing VEGFR2, and the pattern of microbubble distribution was correlated with the pattern of receptor expression determined by immunocytochemistry. The binding of targeted microbubbles on cells was competed off by an excess of free lipopeptide, the natural ligand (VEGF) and by a VEGFR2-specific antibody (P < 0.001). Although selected for the human receptor, the VEGFR2-binding lipopeptide was also shown to recognize the rodent receptor. Tumor perfusion was assessed during the vascular phase of BR55, and then the malignant lesion was highlighted by specific accumulation of the targeted microbubbles on tumoral endothelium. The presence of VEGFR2 was confirmed by immunofluorescence staining of tumor cryosections. CONCLUSIONS: VEGFR2-targeted ultrasound contrast agents such as BR55 will likely prove useful in human for the early detection of tumors as well as for the assessment of response to specific treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527
Angiogenesis in life, disease and medicine
Carmeliet, P. (2005) · Nature · doi:10.1038/nature04478 · Cited by 3,482
Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
Hicklin, D. J., & Ellis, L. M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.081 · Cited by 3,007
Angiogenesis as a therapeutic target
Ferrara, N., & Kerbel, R. S. (2005) · Nature · doi:10.1038/nature04483 · Cited by 2,653
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
Ferrara, N., Hillan, K. J., Gerber, H.-P., & Novotny, W. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1381 · Cited by 2,625
Kerbel, R. S. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0706596 · Cited by 1,948
Folkman, J. (2006) · Annual Review of Medicine · doi:10.1146/annurev.med.57.121304.131306 · Cited by 1,209
Differential Roles of Vascular Endothelial Growth Factor Receptor-1 and Receptor-2 in Angiogenesis
Shibuya, M. (2006) · BMB Reports · doi:10.5483/bmbrep.2006.39.5.469 · Cited by 623
Willmann, J. K., Paulmurugan, R., Chen, K., Gheysens, O., Rodriguez-Porcel, M., Lutz, A. M., Chen, I. Y., Chen, X., & Gambhir, S. S. (2008) · Radiology · doi:10.1148/radiol.2462070536 · Cited by 301
Monitoring Response to Anticancer Therapy by Targeting Microbubbles to Tumor Vasculature
Korpanty, G., Carbon, J. G., Grayburn, P. A., Fleming, J. B., & Brekken, R. A. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1313 · Cited by 245
Dual-targeted Contrast Agent for US Assessment of Tumor Angiogenesis in Vivo
Willmann, J. K., Lutz, A. M., Paulmurugan, R., Patel, M. R., Chu, P., Rosenberg, J., & Gambhir, S. S. (2008) · Radiology · doi:10.1148/radiol.2483072231 · Cited by 207
Palmowski, M., Huppert, J., Ladewig, G., Hauff, P., Reinhardt, M., Mueller, M. M., Woenne, E. C., Jenne, J. W., Maurer, M., Kauffmann, G. W., et al. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0409 · Cited by 170
Gabhann, F. M., & Popel, A. S. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00254.2003 · Cited by 156
Molecular ultrasound imaging using microbubble contrast agents
Dayton, P. A. (2007) · Frontiers in bioscience · doi:10.2741/2553 · Cited by 152
Modulating Targeted Adhesion of an Ultrasound Contrast Agent to Dysfunctional Endothelium
Weller, G. E. R., Villanueva, F. S., Klibanov, A. L., & Wagner, W. R. (2002) · Annals of Biomedical Engineering · doi:10.1114/1.1513565 · Cited by 136
Chinol, M., Casalini, P., Maggiolo, M. J., Canevari, S., Omodeo, E., Caliceti, P., Veronese, F. M., Cremonesi, M., Chiolerio, F., Nardone, E., et al. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.463 · Cited by 132
Lyshchik, A. P., Fleischer, A. C., Huamani, J., Hallahan, D. E., Briššová, M., & Gore, J. C. (2007) · Journal of Ultrasound in Medicine · doi:10.7863/jum.2007.26.11.1575 · Cited by 123
Targeting vascular endothelium with avidin microbubbles
Korpanty, G. J., Grayburn, P. A., Shohet, R. V., & Brekken, R. A. (2005) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2005.06.001 · Cited by 88
Lee, D. J., Lyshchik, A. P., Huamani, J., Hallahan, D. E., & Fleischer, A. C. (2008) · Journal of Ultrasound in Medicine · doi:10.7863/jum.2008.27.6.855 · Cited by 87
High Sensitivity: High-Resolution SPECT-CT/MR Molecular Imaging of Angiogenesis in the Vx2 Model
Lijowski, M., Caruthers, S., Hu, G., Zhang, H., Scott, M. J., Williams, T., Erpelding, T., Schmieder, A. H., Kiefer, G., Gulyas, G., et al. (2009) · Investigative Radiology · doi:10.1097/rli.0b013e31818935eb · Cited by 79
Hauff, P., Reinhardt, M., Briel, A., Debus, N., & Schirner, M. (2004) · Radiology · doi:10.1148/radiol.2313030425 · Cited by 78
Palmowski, M., Morgenstern, B., Hauff, P., Reinhardt, M., Huppert, J., Mäurer, M., Woenne, E. C., Doerk, S., Ladewig, G., Jenne, J. W., et al. (2008) · Investigative Radiology · doi:10.1097/rli.0b013e31815a251b · Cited by 69
A distinct strategy to generate high-affinity peptide binders to receptor tyrosine kinases
Shrivastava, A., von Wronski, M. A., Sato, A. K., Dransfield, D. T., Sexton, D. J., Bogdan, N. J., Pillai, R., Nanjappan, P., Song, B., Marinelli, E. R., et al. (2005) · Protein Engineering Design and Selection · doi:10.1093/protein/gzi049 · Cited by 55
Drug Insight: antiangiogenic therapies for gastrointestinal cancers—focus on monoclonal antibodies
Reinacher‐Schick, A., Pohl, M., & Schmiegel, W. (2008) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep1097 · Cited by 41
Raatschen, H., Fu, Y., Brasch, R. C., Pietsch, H., Shames, D. M., & Yeh, B. M. (2009) · Investigative Radiology · doi:10.1097/rli.0b013e31819f1b60 · Cited by 25
In Vivo Ultrasound Imaging of Thrombi Using a Target-Specific Contrast Agent
Tardy, I., Pochon, S., Théraulaz, M., Nanjappan, P., & Schneider, M. (2002) · Academic Radiology · doi:10.1016/s1076-6332(03)80207-6 · Cited by 22
Self-citation
Cited by
Molecular imaging: current status and emerging strategies
Pysz, M. A., Gambhir, S. S., & Willmann, J. K. (2010) · Clinical Radiology · doi:10.1016/j.crad.2010.03.011 · Cited by 572
Molecular ultrasound imaging: current status and future directions
Deshpande, N., Needles, A., & Willmann, J. K. (2010) · Clinical Radiology · doi:10.1016/j.crad.2010.02.013 · Cited by 306
Ultrasound Microbubbles for Molecular Diagnosis, Therapy, and Theranostics
Kiessling, F., Fokong, S., Koczera, P., Lederle, W., & Lammers, T. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.099754 · Cited by 305
A targeted approach to cancer imaging and therapy
Li, C. (2014) · Nature Materials · doi:10.1038/nmat3877 · Cited by 268
Nanoparticles for Imaging: top or Flop?
Kiessling, F., Mertens, M. E., Grimm, J., & Lammers, T. (2014) · Radiology · doi:10.1148/radiol.14131520 · Cited by 228
Metadata
- Authors
- Pochon, S., Tardy, I., Bussat, P., Bettinger, T., Brochot, J., von Wronski, M., Passantino, L., & Schneider, M.
- Venue
- Investigative Radiology
- Published
- 2010-02
- Volume
- 45
- Issue
- 2
- Pages
- 89-95
- ISSN
- 0020-9996 (ISSN-L)
- OpenAlex
- W1982574363
- Cited by
- 266
- References
- 26
- FWCI
- 16.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.